PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
30856079-0	2018	Vitamin D3 supplementation improves serum SFRP5 and Wnt5a levels in patients with type 2 diabetes: A randomized, double-blind, placebo-controlled trial.	Cholecalciferol	0-10	Wnt family member 5A	Homo sapiens	52-57	
30856079-1	2018	Objective: To explore the effect of vitamin D3 on novel serum adipokines, secreted frizzled-related protein 5 (SFRP5) and Wingless-Type MMTV Integration Site Family Member 5a (Wnt5a) levels in Type 2 Diabetes Mellitus (T2DM) patients.	Cholecalciferol	36-46	Wnt family member 5A	Homo sapiens	176-181	
30856079-9	2018	Conclusion: 8 weeks of vitamin D3 supplementation for patients with type 2 diabetes may increase serum anti-inflammatory adipokine SFRP5 but decrease serum pro-inflammatory Wnt5a and TNF-alpha.	Cholecalciferol	23-33	Wnt family member 5A	Homo sapiens	173-178